PROLENSA (bromfenac ophthalmic solution) 0.07% > Home
WEBPROLENSA (bromfenac ophthalmic solution) 0.07% is a nonsteroidal anti-inflammatory drug (NSAID) indicated to treat inflammation and reduce eye pain in patients after cataract surgery. PROLENSA® contains sodium sulfite, a substance that may cause allergic reactions, some severe, in certain people.
DELIVER THE PROLENSA
WEBPROLENSA ® (bromfenac ophthalmic solution) 0.07% is a nonsteroidal anti-inflammatory drug (NSAID) indicated for the treatment of postoperative inflammation and reduction of ocular pain in patients who have undergone cataract surgery.
Save on PROLENSA
WEBThe PROLENSA Part D Program offers savings for Medicare Part D patients. Most eligible patients pay as little as an $80 copay on their PROLENSA ® prescription. †
About PROLENSA
WEBTreatment of inflammation and pain after cataract surgery. PROLENSA ® reduced inflammation in eyes as early as 8 days after cataract surgery. About 4 out of 5 patients taking PROLENSA ® were pain-free the day after surgery with one dose given the day of surgery*. *Individual results may vary.
EMPOWER YOUR PRACTICE WITH - why-prolensa?
WEBPROLENSA ® (bromfenac ophthalmic solution) 0.07% is a nonsteroidal anti-inflammatory drug (NSAID) indicated for the treatment of postoperative inflammation and reduction of ocular pain in patients who have undergone cataract surgery.
FAQs - prolensarx.com
WEBPROLENSA ® is a nonsteroidal anti-inflammatory drug (NSAID) taken as an eye drop. Your doctor will have you take PROLENSA ® one day before surgery, on the day of your surgery, and once daily through the treatment period. If you have further questions about PROLENSA ®, talk to your eye doctor.
POWERED FOR PATIENT SAVINGS - prolensarx.com
WEBThe PROLENSA Part D Program offers savings for Medicare Part D patients. Most eligible patients pay as little as an $80 copay on their PROLENSA ® prescription. †
WEBPROLENSA® (bromfenac ophthalmic solution) 0.07% is a nonsteroidal anti-inflammatory drug (NSAID) indicated to treat inflammation and reduce eye pain in patients after cataract surgery. IMPORTANT SAFETY INFORMATION
POWERED FOR PENETRATION - prolensarx.com
WEBPROLENSA ® (bromfenac ophthalmic solution) 0.07% is a nonsteroidal anti-inflammatory drug (NSAID) indicated for the treatment of postoperative inflammation and reduction of ocular pain in patients who have undergone cataract surgery.
POWERED FOR EFFICACY - prolensarx.com
WEBIndications and usage. PROLENSA ® (bromfenac ophthalmic solution) 0.07% is a nonsteroidal anti-inflammatory drug (NSAID) indicated for the treatment of postoperative inflammation and reduction of ocular pain in patients who have undergone cataract surgery.